LCN2 and acute kidney injury: Recent advancements in diagnostic approaches, including the application of biomarkers like Neutrophil Gelatinase-Assapplying (NGAL) and Liver Fatty Acid-Binding Protein (LFABP), have shown promise in early AKI detection [6].